Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sung-Im DO

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Anticancer Research|June 1, 2018
Stromal p16 Overexpression in Gastric-type Mucinous Carcinoma of the Uterine CervixTaek Chung, Sung-Im DO, Kiyong Na, et al.
Anticancer Research|August 30, 2022
Assessing Resection Margin Status in Breast-conserving Surgery Specimens: Comparison Among Gross Evaluation, Frozen Section Analysis, and Permanent Section Diagnosis in 725 Patients With Breast CancerJeongeun DO, Jinah Chu, Jaeyoung Ahn, et al.
Cancer Genomics & Proteomics|October 25, 2020
Atypical Mesonephric Hyperplasia of the Uterus Harbors Pathogenic Mutation of Kirsten Rat Sarcoma 2 Viral Oncogene Homolog (<i>KRAS</i>) and Gain of Chromosome 1qHyunjin Kim, Nara Yoon, Ha Young Woo, et al.
Oncology Letters|February 10, 2015
Expression of phosphorylated extracellular signal-regulated kinase at the invasive front of hepatic colorectal metastasisHyun-Soo Kim, Sung-Im DO, Byeong-Joo Noh, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 17, 2017
Expression of epithelial-mesenchymal transition driver brachyury and status of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in predicting treatment responses to neoadjuvant chemotherapy of breast cancerKwan Ho Lee, Eun Young Kim, Yong Lai Park, et al.
Journal of Gynecologic Oncology|October 20, 2020
Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancerJee Suk Chang, Nalee Kim, Ji Ye Kim, et al.
Oncology Letters|September 26, 2017
High excision repair cross-complementation group 1 expression is associated with favorable prognostic factors in breast cancerDong Hyun Kim, Hyunjoo Lee, Dong-Hoon Kim, et al.
Tumori|August 19, 2008
Expression of embryonic lethal abnormal vision (ELAV)-like protein HuR and cyclooxygenase-2 (COX-2) in Ewing sarcomaSung-Im Do, Eduard Santini Araujo, Ricardo K Kalil, et al.
In Vivo (Athens, Greece)|October 29, 2022
Clinicopathological and Prognostic Significance of Programmed Death Ligand-1 SP142 Expression in 132 Patients With Triple-negative Breast CancerJinah Chu, Min-Kyung Yeo, Sang Hwa Lee, et al.
Journal of Personalized Medicine|August 27, 2021
High BMI1 Expression with Low CD8+ and CD4+ T Cell Activity Could Promote Breast Cancer Cell Survival: A Machine Learning ApproachYumin Chung, Kyueng-Whan Min, Dong-Hoon Kim, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Anticancer Research|June 1, 2018
Stromal p16 Overexpression in Gastric-type Mucinous Carcinoma of the Uterine CervixTaek Chung, Sung-Im DO, Kiyong Na, et al.
Anticancer Research|August 30, 2022
Assessing Resection Margin Status in Breast-conserving Surgery Specimens: Comparison Among Gross Evaluation, Frozen Section Analysis, and Permanent Section Diagnosis in 725 Patients With Breast CancerJeongeun DO, Jinah Chu, Jaeyoung Ahn, et al.
Cancer Genomics & Proteomics|October 25, 2020
Atypical Mesonephric Hyperplasia of the Uterus Harbors Pathogenic Mutation of Kirsten Rat Sarcoma 2 Viral Oncogene Homolog (<i>KRAS</i>) and Gain of Chromosome 1qHyunjin Kim, Nara Yoon, Ha Young Woo, et al.
Oncology Letters|February 10, 2015
Expression of phosphorylated extracellular signal-regulated kinase at the invasive front of hepatic colorectal metastasisHyun-Soo Kim, Sung-Im DO, Byeong-Joo Noh, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 17, 2017
Expression of epithelial-mesenchymal transition driver brachyury and status of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in predicting treatment responses to neoadjuvant chemotherapy of breast cancerKwan Ho Lee, Eun Young Kim, Yong Lai Park, et al.
Journal of Gynecologic Oncology|October 20, 2020
Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancerJee Suk Chang, Nalee Kim, Ji Ye Kim, et al.
Oncology Letters|September 26, 2017
High excision repair cross-complementation group 1 expression is associated with favorable prognostic factors in breast cancerDong Hyun Kim, Hyunjoo Lee, Dong-Hoon Kim, et al.
Tumori|August 19, 2008
Expression of embryonic lethal abnormal vision (ELAV)-like protein HuR and cyclooxygenase-2 (COX-2) in Ewing sarcomaSung-Im Do, Eduard Santini Araujo, Ricardo K Kalil, et al.
In Vivo (Athens, Greece)|October 29, 2022
Clinicopathological and Prognostic Significance of Programmed Death Ligand-1 SP142 Expression in 132 Patients With Triple-negative Breast CancerJinah Chu, Min-Kyung Yeo, Sang Hwa Lee, et al.
Journal of Personalized Medicine|August 27, 2021
High BMI1 Expression with Low CD8+ and CD4+ T Cell Activity Could Promote Breast Cancer Cell Survival: A Machine Learning ApproachYumin Chung, Kyueng-Whan Min, Dong-Hoon Kim, et al.
Pageof 9